Progressive rise in red cell distribution width is associated with poor outcome after transcatheter aortic valve implantation

Heart

Volumn 99, Issue 17, 2013, Pages 1261-1266

  Aung, Nay ^a   Dworakowski, Rafal ^a   Byrne, Jonathan ^a   Alcock, Emma ^a   Deshpande, Ranjit ^a   Rajagopal, Kailasam ^a   Brickham, Beth ^a   Monaghan, Mark J ^a   Okonko, Darlington O ^b   Wendler, Olaf ^a   MacCarthy, Philip A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; HEMOGLOBIN; UREA;

AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; ARTICLE; CELLULAR DISTRIBUTION; DEATH; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY; RED CELL DISTRIBUTION WIDTH; RETROSPECTIVE STUDY; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE; ERYTHROCYTE INDICES; FEMALE; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84881481069     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-303910     Document Type: Article

References (40)

1. Ryan DH. Examination of the blood. In: Lichtman MA.ed. Williams hematology. 7th edn. New York: McGraw-Hill, 2005:P11-19.
2. Demir A, Yarali N, Fisgin T, et al. Most reliable indices in differentiation between thalassemia trait and iron deficiency anemia. Pediatr Int 2002;44:612-16. (Pubitemid 35357026)
3. Forhecz Z, Gombos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function and nutritional state. Am Heart J 2009;158:659-66.
4. Allen LA, Felker GM, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Cardiac Fail 2010;16:230-8.
5. Lippi G, Targher G, Montagnana M, et al. Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. Scand J Clin Lab Invest 2008;68:745-8.
6. Jackson CE, Dalzell JR, Bezlyak V, et al. Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. Eur J Heart Fail 2009;11:1152-4.
7. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007;50:40-7. (Pubitemid 46963527)
8. Dabbah S, Hammerman H, Markiewicz W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 2010;105:312-17.
9. Rhodes CJ, Wharton J, Howard LS, et al. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart 2011;97:1054-60.
10. Benedetto U, Angeloni E, Melina G, et al. Red blood cell distribution width predicts mortality after coronary artery bypass grafting. Int J Cardiol 2013;165:369-71.
11. Braunwald Jr J, Ross E. Aortic stenosis. Circulation 1968;38(1 Suppl):61-7.
12. Dewey TM, Brown DL, Das TS, et al. High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg 2008;86:1450-6.
13. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 2012;33:2403-18.
14. Dworakowski R, MacCarthy PA, Monaghan M, et al. Transcatheter aortic valve implantation for severe aortic stenosis-a new paradigm for multidisciplinary intervention: a prospective cohort study. Am Heart J 2010;160:237-43.
15. Levey AS, Bosch JP, Lewis JB, et al. For the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.
16. Hampole CV, Mehrotra AK, Thenappan T, et al. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 2009;104:868-72.
17. Fatemi O, Paranilam J, Rainow A, et al. Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. J Thromb Thrombolysis 2013;35:57-64.
18. Akarsu S, Taskin E, Yilmaz E, et al. Treatment of iron deficiency anemia with intravenous iron preparations. Acta Haematol 2006;116:51-7. (Pubitemid 43990958)
19. Aslan D, Gumruk F, Gurgey A, et al. Importance of RDW value in differential diagnosis of hypochrome anemias. Am J Hematol 2002;69:31-3.
20. Bessman JD, Gilmer PR, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol 1983;80:322-6. (Pubitemid 13048993)
21. Stöhr R, Dohmen G, Herpertz R, et al. Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison. Coron Artery Dis 2011;22:595-600.
22. Stortecky S, Schoenenberger AW, Moser A, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012;5:489-96.
23. D'Ascenzo F, Moretti C, Salizzoni S,, et al 30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study. Int J Cardiol 2012. [Epub ahead of print]
24. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90.
25. Cruz NG, Sousa LP, Sousa MO, et al. The linkage between inflammation and Type 2 diabetes mellitus. Diabetes Res Clin Pract 2013;99:85-92.
26. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7. (Pubitemid 30430551)
27. Müller S, Martin S, Koenig W, et al. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 2002;45:805-12.
28. Ben-Dor I, Goldstein SA, Pichard AD, et al. Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol 2011;107:1046-51.
29. Gotzmann M, Rahlmann P, Hehnen T, et al. Heart failure in severe aortic valve stenosis: prognostic impact of left ventricular ejection fraction and mean gradient on outcome after transcatheter aortic valve implantation. Eur J Heart Fail 2012;14:1155-62.
30. Di Mario C, Eltchaninoff H, Moat N, et al. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention 2013;8:1362-71.
31. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-8.
32. Wenaweser P, Pilgrim T, Roth N, et al. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J 2011;161:1114-24.
33. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-33.
34. Röhrig G, Doehner W, Schaefer RM, et al. Anemia and iron deficiency in the elderly. Prevalence, diagnostics and new therapeutic options. Z Gerontol Geriatr 2012;45:191-6.
35. Okonko DO, Mandal AK, Missouris CG, et al. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 2011;58:1241-51.
36. Sinning JM, Ghanem A, Steinhäuser H, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010;3:1141-9.
37. Elhmidi Y, Bleiziffer S, Piazza N, et al. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J 2011;161:735-9.
38. Sun LJ, Zhang FC, Li D, et al. The impact of serum total bilirubin level on long-term prognosis in patients with chronic heart failure. Zhonghua Nei Ke Za Zhi 2012;51:677-9.
39. Dworakowski R, Wendler O, Bhan A, et al. Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction. Heart 2012;98:1641-6.
40. van Kimmenade RR, Mohammed AA, Uthamalingam S, et al. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 2010;12:129-36.